IPO registrations (S-1, F-1) · Registrants
ANAVEX LIFE SCIENCES CORP.
- SEC CIK
- 1314052 · filings on EDGAR ↗
- Former names
- Thrifty Printing Inc. (2005–2007)
- Registration
- Form S-1, first filed 2013-09-04, last 2015-03-05; 4 initial registrations, 3 amendments
- Outcome
- Declared effective 2013-10-01
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Business address
- 630 5TH AVENUE, 20TH FLOOR, New York, NY 10111
- EIN
- 98-0608404
- Ticker
- AVXL (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ANAVEX LIFE SCIENCES CORP. on the corporate pages
Offering terms
- Shares offered
- 15,486,358
- Listing
- OTCQX under the symbol AVXL
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ANAVEX LIFE SCIENCES CORP. Fuzzy (name and state)
- Form D issuer: ANAVEX LIFE SCIENCES CORP. EXACT (CIK (EXACT))
- Lobbying client: ANAVEX LIFE SCIENCES Fuzzy (name and state)
- SEC filer: ANAVEX LIFE SCIENCES CORP. EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-09-04 | S-1 | S-1 (registration) | ANAVEX LIFE SCIENCES CORP. | 0001062993-13-004523 ↗ |
| 2013-09-24 | S-1/A | S-1/A (amendment) | ANAVEX LIFE SCIENCES CORP. | 0001062993-13-004768 ↗ |
| 2013-09-25 | S-1/A | S-1/A (amendment) | ANAVEX LIFE SCIENCES CORP. | 0001062993-13-004779 ↗ |
| 2013-10-01 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-13-002852 ↗ |
| 2013-10-10 | S-1 | S-1 (registration) | ANAVEX LIFE SCIENCES CORP. | 0001062993-13-004987 ↗ |
| 2013-10-23 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-13-003056 ↗ |
| 2014-04-11 | S-1 | S-1 (registration) | ANAVEX LIFE SCIENCES CORP. | 0001062993-14-002104 ↗ |
| 2014-07-10 | S-1/A | S-1/A (amendment) | ANAVEX LIFE SCIENCES CORP. | 0001062993-14-004124 ↗ |
| 2014-07-23 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-14-002195 ↗ |
| 2014-08-22 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-14-002582 ↗ |
| 2015-03-05 | S-1 | S-1 (registration) | ANAVEX LIFE SCIENCES CORP. | 0001062993-15-001191 ↗ |
| 2015-03-24 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-15-000682 ↗ |
| 2015-07-08 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-15-001857 ↗ |
| 2016-09-06 | EFFECT | EFFECT (declared effective) | ANAVEX LIFE SCIENCES CORP. | 9999999995-16-005616 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-05 | S-1 | registration statement | $0.30 | 15,486,358 | $4,645,907 | OTCQX AVXL | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Lalach Harvey | Director,Officer | President; President & CEO; President CEO CFO; President, CFO; President COO Secretary | 10 | 2006–2012 | |
| Skarpelos Athanasios | Director; Director,TenPercentOwner; TenPercentOwner | 19 | 2006–2025 | ||
| Wu Pei Ru | Director,Officer,TenPercentOwner | COO | 1 | 2006 | |
| Wu Yang | Director,Officer,TenPercentOwner | President & CEO | 1 | 2006 | |
| Kontzalis Panos | Director,Officer | CEO | 2 | 2007 | |
| Vamvakides Alexandre | Director,Officer | Chief Scientific Officer | 1 | 2007 | |
| Kalkanis George | Officer | VP Strategic Planning | 2 | 2007 | |
| Vernadaki Angela | Officer | VP Business Development | 2 | 2007 | |
| Durrant Cameron | Director; Director,Officer | Executive Chairman | 5 | 2007–2011 | |
| Ayers Alison E. | Director | 4 | 2008–2010 | ||
| Tousley David L. | Director | 4 | 2008–2010 | ||
| KERGROHEN HERVE DE | Officer | CEO | 1 | 2009 | |
| Lowry William Sean | Director | 1 | 2011 | ||
| Chisholm John Robert | Director | 1 | 2011 | ||
| TIDMARSH GEORGE F | Director,Officer | Executive Director | 2 | 2011–2012 | |
| MISSLING CHRISTOPHER U | Director,Officer; Director,OfficerOther | Chief Executive Officer; Director, President & CEO; Pres, CEO, CFO, Treas, Secy.; President and CEO; President & CEO; President, CEO, CFO, Treasurer; President,CEO,CFO & Treasurer; President, CEO & Treasurer | 62 | 2013–2026 | |
| FAVUS ELLIOT | Director | 11 | 2014–2021 | ||
| METZNER BERND | Director | 3 | 2014–2016 | ||
| Thomas Steffen | Director | 12 | 2015–2025 | ||
| Boenisch Sandra | Officer | PFO and Treasurer; PFO & Treasurer; Principal Financial Officer | 20 | 2015–2026 | |
| Donhauser Peter D.O. | Director | 12 | 2017–2025 | ||
| Velden Claus Vander | Director | 9 | 2018–2025 | ||
| Ma Jiong | Director | 6 | 2021–2025 | ||
| Paeger Axel | Director | 1 | 2026 | ||
| Kellmeyer Terrie | Officer | Interim CEO | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-04-02 | ANAVEX LIFE SCIENCES CORP. | Biotechnology | $10,000,000 | $10,000,000 | 11 | 1 |
| 2012-02-16 | ANAVEX LIFE SCIENCES CORP. | Biotechnology | $10,000 | $10,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ANAVEX LIFE SCIENCES CORP. | NY | State business registries | name and state |
| Form D issuer | ANAVEX LIFE SCIENCES CORP. | NY | Form D private offerings | CIK (EXACT) |
| Lobbying client | ANAVEX LIFE SCIENCES | NY | Federal lobbying (LDA) | name and state |
| Patent assignee | ANAVEX LIFE SCIENCES CORP. | NY | Patents (USPTO) | name and state |
| SEC filer | ANAVEX LIFE SCIENCES CORP. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Anavex Life Sciences Corp. | NY | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NY first:
- Acorda Therapeutics, Inc. NY
- BRAINSTORM CELL THERAPEUTICS INC. NY
- CytRx Oncology Corp NY
- Omrix Biopharmaceuticals, Inc. NY
- Protara Therapeutics, Inc. NY
- COGNITION THERAPEUTICS INC NY
- Bavarian Nordic A/S / ADR NY
- Qrons Inc. NY
- Prevail Therapeutics Inc. NY
- MeiraGTx Holdings plc NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health